FIGURE

Fig. 4

ID

ZDB-FIG-190809-11

Publication

Lin et al., 2019 - Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index than Sorafenib via Zebrafish Drug Screening Platform

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

The dose–response fitting mortality curve of wide-type embryos treated with 419S1, 420S1, and Sorafenib for five days, starting six hours post-fertilization. (A) Embryos treated with Sorafenib had a significantly higher mortality rate compared to 419S1 and 420S1. (B) Representative images of wild-type embryos treated with 419S1, 420S1, and Sorafenib at specified concentrations for five days. Abnormal embryonic phenotypes are shown with arrows. Red arrow: pericardial edema; green arrow: retarded yolk sac reabsorption; black arrow: retarded swim bladder inflation; blue arrow: spinal curvature and/or short body length. Scale bar: 0.2mm.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers